NCT05950152

Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal Surgery

A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of Meloxicam Injection in Subjects After Abdominal Surgery

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 108 (estimated)
• Sponsor: Beijing Tide Pharmaceutical Co., Ltd · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine the analgesic efficacy and safety of Meloxicam Injection in subjects undergoing abdominal surgery.

Conditions

• Pain, Post-operative

Interventions

Type	Name	Description
DRUG	Meloxicam Injection 30mg	meloxicam injection 30mg every 24 hours for up to 2 dose
DRUG	Meloxicam Injection 60mg	meloxicam injection 60mg every 24 hours for up to 2 dose
DRUG	Nacl 0.9%	IV Placebo every 24 hours for up to 2 doses

Timeline

• Start date: 2023-07-01
• Primary completion: 2023-12-01
• Completion: 2024-02-01
• First posted: 2023-07-18
• Last updated: 2023-07-18

Locations

1 site across 1 country: China